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ABSTRACT 
Oral lichen planus (OLP) is a T-cell mediated chronic inflammatory disease with 
different clinical types that remains inscrutable in respect of its pathogenetic mechanisms and 
effective therapy. Increased apoptosis may influence the histopathological criteria of oral 
lichen planus (decrease in thickness of the epithelium and band of inflammatory infiltrate). 
 
Null hypothesis 
The apoptotic rate does not correlate with a decrease in the epithelial thickness as well 
as the thickness of the band of inflammatory infiltrate in OLP. 
 
Aim 
The present study aims to quantify apoptotic activity and to correlate the apoptotic 
rate with epithelial thickness as well as thickness of the inflammatory infiltrate of OLP cases 
diagnosed at Tygerberg Hospital from 2006 – 2015. Further, the epithelial thickness and 
thickness of the inflammatory infiltrate were also assessed for their association, if any.  
 
Materials and Methods 
The study sample comprised 17 diagnostically verified cases of OLP. Sections stained 
with Haematoxylin and Eosin (H&E) were used to identify and count the number of apoptotic 
cells as well as measure the thickness of epithelium and the thickness of the lymphocytic 
inflammatory infiltrate by using software morphometric analysis (Zen Blue lite 2012). 
Statistical analysis was applied to analyse the correlation between apoptotic cells and 
histopathological features of OLP. 
 
Results 
The present study’s results showed no statistically significant association between the 
apoptotic rate, the epithelial thickness and the thickness of the lymphocytic inflammatory 
infiltrate. 
 
Keywords: Apoptosis, Oral Lichen Planus, Epithelial thickness, Inflammatory infiltrate 
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CHAPTER 1 
 
 
INTRODUCTION 
 
The term “lichen planus” is derived from the Latin word lichen, meaning “ringworm”, 
and the Greek word planus meaning “flat”, and refers to the clinical appearance of the skin 
papulae which appear depressed, flattened and smooth (Wilson, 1869). OLP is a commonly 
encountered disease in clinical dental practice, affecting approximately 0.5% to 2.0% of the 
entire population (McCreary and McCartan, 1999). Lichen planus is thus a chronic 
inflammatory disease which can affect both the mucosal and cutaneous tissues. The 
cutaneous form of OLP is less common than the mucosal form with reduced resistance to 
treatment in comparison to the mucosal form (Mollaoglu, 2000). Furthermore, OLP has been 
defined by the World Health Organization (WHO) as a potentially pre-cancerous disorder 
(WHO 1978; Georgakopoulou et al., 2012). OLP is present in a variety of clinical forms 
(Andreasen, 1968) and it is histologically characterised by a band-like lympho-histiocytic 
infiltrate that occupies the superficial layer of the lamina propria (interface mucositis). In 
addition, vacuolar degeneration of the basal keratinocytes with absence of epithelial dysplasia 
are other important characteristics of OLP (Van der Meij and Van der Waal, 2003). 
Although the key mechanisms involved in OLP pathogenesis are not fully understood, 
the role of a dysregulated immune response has been implicated in the condition. It is 
hypothesised that, due to the abnormal immune response, the antigenicity of the surface 
epithelial cells is altered resulting in the recognition of self-epithelial cells as foreign cells 
and subsequently their destruction by T-lymphocytes (Patel et al., 2005; Sugerman and 
Savage, 2002). Further, apoptosis has also been reported as the key mechanism by which 
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epidermal cells die, leading to the destruction of epithelium and reduction of its thickness 
(Brant et al., 2012; Doddawad, 2014). However, the role of apoptosis in the inflammatory 
infiltrate of OLP is poorly understood as, to date, most of the studies on apoptosis in OLP 
have repeatedly focused   on   the   epithelium   and   not   on   the combinatorial   effect   of 
apoptosis on the epithelium and the inflammatory cells. Keeping the above facts in mind, the 
present study aims to investigate the link between the apoptotic rate with epithelial thickness 
and intensity of the inflammatory infiltrate and to correlate between the thickness of the 
epithelium and the thickness of the band of inflammatory infiltrate in OLP samples. This 
retrospective study was conducted on OLP lesions in patients registered at the Oral Health 
Centre of the Tygerberg Hospital in Cape Town from 2006 to 2015. Morphometric analysis 
software (Zen Blue Lite 2012) was used to identify and count the number of apoptosis and to 
detect whether apoptosis should be an important component of the histopathological criteria 
in OLP.  It is expected that the findings from this study will improve our understanding of the 
role of apoptosis in OLP in relation to the other histopathological features. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1  STRUCTURE OF THE HEALTHY MUCOSA  
 
The oral cavity is lined by a mucous membrane comprising epithelium and underlying 
supporting tissue. It is broadly classified into keratinised and non-keratinised types of oral 
mucosa depending on its location and functions. While the keratinised oral mucosa is located 
in areas that are subjected to masticatory force, such as the hard palate and the marginal 
gingival (resembling the epidermis of the skin), the non-keratinised epithelium is located in 
the alveolar mucosa, buccal mucosa, floor of the mouth, ventral tongue, lips and soft palate. 
Some areas of the mouth consist of both keratinised and non-keratinised types of epithelium, 
like the vermilion border of the lip and the dorsal surface of the tongue (Dale et al., 1990; 
Presland and Dale, 2000; Presland and Jurevic, 2002). 
The lining epithelium of oral mucosa is of the stratified squamous type (Mackenzie 
and Fusenig, 1983), and the underlying supporting tissue (lamina propria) contains blood 
vessels, nerves, fat and muscles. These two layers (oral epithelium and supporting tissue) are 
separated by dense connective tissue material called the basement membrane comprising 
collagen Type 4 (Ten Cate, 1998). 
2.2  EPIDEMIOLOGY OF ORAL LICHEN PLANUS  
 
OLP is considered to be a common condition which affects about 0.5 – 2.2% of the 
world population (McCreary and McCartan, 1999). The disease mainly appears in the 
middle-aged population, in particular in individuals between 30 and 50 years of age and is 
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more common in females than in males (Brown et al., 1993). OLP is uncommon in children 
and if it affects children, it usually presents as a cutaneous form of lichen planus (Alam and 
Hamburger, 2001). The rate of recovery from OLP is only about 17% of affected people 
(Thorn et al., 1988). 
2.3  CLINICAL FEATURES  
 
OLP is clinically represented and recognised in multiple forms including reticular, 
papular, plaque, atrophic, ulcerative (erosive) and a rare bullous form (Andreasen, 1968; 
Ismail et al., 2007). The disease tends to be bilateral and occurs commonly on the buccal 
mucosa area of the oral cavity (Bagan-Sebastián et al., 1992). Other areas that can be affected 
include the palate, gingiva, tongue and alveolar ridge. 
OLP always affects the oral mucosa bilaterally.  The most common form of OLP 
lesions is the reticular type which typically appears with an erythematous border and 
interlacing white hyperkeratosis lines referred to as Wickham’s striae (Ingafou et al., 2006). 
The second most common type of OLP is the atrophic type which appears as diffuse, 
erythematous patches (Thorn et al., 1988). The bullous form is commonly situated in the 
buccal mucosa or at the lateral border of the tongue. This form ruptures easily and presents as 
an erosive type of OLP (Thorn et al., 1988). The most destructive forms are the 
ulcerative/erosive types. These are associated with more pain and oral discomfort compared 
to the white reticular forms which usually present fewer symptoms (Brant et al., 2012). The 
erosive form appears clinically as a central ulceration covered by a pseudo-membrane or a 
fibrin plaque and is often surrounded by fine radiant keratinised striae with a network 
appearance (Neville and Damm, 1998). 
The papular form appears as small papules of approximately 1.0 mm in size that are 
present in conjunction with other clinical variants, whereas the plaque form resembles 
multifocal leucoplakia which vary from irregular elevated areas to smooth and flat areas 
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(Bricker, 1994). The latter is more common in smokers and most frequently affects the 
tongue and buccal mucosa (Thorn et al., 1988). 
 
 
Figure 1: Clinical features of OLP showing (A) reticular, (B) atrophic (C) erosive, and (D) 
papular variants (Cheng et al., 2016). 
 
 
2.4      HISTOPATHOLOGY  
 
The histopathological features of OLP are highly similar to the cutaneous lichen 
planus. According to the WHO (1978), these features largely include: (1) a dense band-like 
layer of lymphocytic infiltrate within the underlying connective tissue, (2) liquefactive 
degeneration of the basal keratinocytes and (3) absence of epithelial dysplasia. From a 
histopathological view the lesion is considered to be OLP if the lesion includes all of these 
three criteria. In the absence of any one of these three criteria, the lesion is considered to be 
‘histologically compatible with OLP’ (Fernández et al., 2011). Other histopathological 
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features of the lesion include hyperkeratosis (hyper-parakeratosis, hyper-orthokeratosis or a 
combination) and eosinophilic apoptotic keratinocytes also known as Civatte bodies 
(Burgdorf and Plewig, 2014).  The mingling of the lymphocytes with the basal cell area is 
referred to as “interface mucositis” and can also be seen in other oral lesions like oral 
lichenoid lesions and Lupus erythromatosus (Jorizzo et al., 1992; Khudhur et al., 2014). In 
addition, other features reported in the literature include the presence of basement membrane 
alterations such as branches, breaks, and thickenings (Jungell et al., 1988). These abnormal 
changes in the basement membrane and basal cells create clefts between the epithelium and 
the underlying lamina propria called the Max-Joseph spaces.  Cleft formation can also result 
in the formation of a blister of the oral mucosa as seen in bullous OLP (Sugerman et al., 
2002). Additional findings reported a thinner epithelium in comparison to normal mucosa 
with “saw-tooth” shaped rete pegs (Karatsaidis et al., 2003; Aminzadeh et al., 2013). 
 
 
 
Figure 2: (A) Typical histopathologic features of OLP. (C) Lymphocytic- mediated injury of 
oral epithelium with keratinocyte apoptosis (arrow) (Cheng et al., 2016). 
 
 
2.5  INFLAMMATORY INFILTRATE IN ORAL LICHEN PLANUS  
 
The band-like inflammatory infiltrate in the sub-epithelial layer of OLP is principally 
composed of T-Cells (CD3+) including T-Helper cells (CD4+) and Cytotoxic T-lymphocytes 
(CD8+) (Hasseus et al., 2001). Previous studies have shown that this inflammatory cell 
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infiltrate is variable in different forms of the disease. CD4+ T-cells predominate in the initial 
lesion of reticular OLP, whereas the numbers of CD8+ T-cells are increased in more 
advanced atrophic or erosive lesions (Sugerman et al., 2002; Charazinska-Carewicz et al., 
2008).  
Langerhans cells (LCs) and mast cells are increased in OLP lesions when compared to 
normal oral mucosa (Zhao et al., 2001; Hasseus et al., 2001). The proportions of B-
lymphocyte and plasma cells in oral lichen planus are relatively lower and represent only 
about 5% of all inflammatory cells (Sugerman et al., 2002). 
 
2.6  AETIOLOGY OF ORAL LICHEN PLANUS  
 
  Although the exact cause of OLP is not completely understood, several studies have 
proposed a number of factors; for example, genetic predisposition, dysregulated immune 
functions, systemic diseases, dental materials, etc, that trigger the development of this lesion. 
While the role of genetic predisposition has been considered in disease pathogenesis, only a 
few familial cases of OLP have been reported. Watanabe and co-workers, among others, have 
stated the role of human leukocyte antigens (HLA) A3, A11, A26, A28, B3, B5, B7, B8, DR1 
in the pathogenesis of oral lichen planus (Watanabe et al., 1986; McCartan and Lamey, 1997; 
Ognjenovie et al., 1998). 
Recently, it was found that pathogenic microorganisms of periodontal origin were 
found to be associated with OLP patients (Ertugrul et al., 2013). Viral agents such as human 
papilloma virus (HPV) were also found to be implicated with OLP lesions (Campisi et al., 
2004). Furthermore, recent studies have also shown a strong connection between Hepatitis C 
Virus (HCV) and OLP (Lodi and Porter, 1997; Prabhu et al., 2002; Gimenez and Perez, 
2003; Lodi et al., 2004).  
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An association between autoimmune disorders such as ulcerative colitis, chronic 
active hepatitis, myasthenia gravis, and OLP lesions has also been reported (Abbate et al., 
2006). Similarly, OLP has been seen in patients affected by neoplasms such as metastatic 
adenocarcinoma as well as breast cancer (Scully et al., 1998). 
Certain systemic diseases like hypertension, Diabetes mellitus, Myasthenia gravis, 
Lupus erythematous, and Ulcerative colitis were also considered to be associated with OLP 
(Lozada and Miranda, 1997). Restoration materials used in dental clinics, such as amalgam, 
silver, cobalt, gold, chromium and composite are believed to stimulate the progression of 
OLP (Issa et al., 2004). 
Other causes like anxiety, stress and food allergies are also considered to be factors 
responsible for the development of OLP (Chaudhary, 2004). Stress has long been implicated 
in the dysregulation of innate and adaptive immune functions through neuro-endocrine 
mediators secreted from the hypothalamus-pituitary-adrenal axis as well as the sympathetic-
adrenal axis (Kemeny and Schedlowski, 2007). Therefore, its influence in OLP pathogenesis, 
most likely as a secondary mechanism, cannot be ruled out. Food allergies with ingredients 
like cinnamon have also been found to trigger the development of OLP (Scully et al., 1998). 
 
2.7  PATHOGENESIS OF ORAL LICHEN PLANUS  
 
      The exact pathogenesis of OLP disease is still unclear, but a large body of evidence 
supports the role of the dysregulated immune system (Scully et al., 1998; Sugerman et al., 
2002; Lodi et al., 2005). Sugerman believes that both the antigen-specific cell mediated 
immune responses as well as non-speciﬁc mechanisms are involved in the pathogenesis of 
OLP. He surmised that other mechanisms like humoral and autoimmune response are also 
involved (Sugerman et al., 2002). 
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       2.7.1  ANTIGEN SPECIFIC MECHANISM 
 
      Although OLP has been recognised as a T-cell mediated inflammatory disease the antigen 
in OLP lesions is yet to be identified (Porter et al., 1997; Sugerman and Savage, 2002). 
Moreover, since it is hypothesised that the body’s own self-peptide or a heat-shock protein 
can act as an antigen, OLP can also be considered as an autoimmune disease. These self-
peptides are induced by many factors such as contact with allergens (e.g. toothpaste or dental 
restorative materials), mechanical trauma, infections (such as bacterial/viral infection), or an 
unidentiﬁed agent (Sugerman and Savage, 2002). 
         Heat shock proteins as antigens are over-expressed in OLP lesions and could be linked 
to a variety of exogenous agents, such as systemic drugs, contact allergens, mechanical 
trauma, bacterial or viral infections (Sugerman et al., 1995). An over-expression of the heat 
shock protein gene by stressed oral keratinocytes, or failure to suppress the response of an 
immune system after self-HSP recognition due to decreased immune response was 
hypothesised in the OLP predisposition (Sugerman and Savage, 2002). 
         The early stages of the disease include expression or unmasking of the keratinocyte 
antigen (Eversole, 1997; Zhou et al., 2002). The response of the immune system to this 
undetermined antigen (heat shock or self-peptide) includes the subsequent stages: 
1. Migration of the T-cells, mainly CD8+ T-cells and a few CD4+ T-cells to the 
epithelium (Sugerman et al., 2002). 
2. Activation of CD8+ T-cells either directly or indirectly. The direct mechanism 
involves the binding of antigen to the MHC‐I on basal keratinocytes. The indirect 
mechanism occurs through binding of antigen to MHC ‐2 on antigen presenting cells 
(APC). This binding leads to the sequential activation of CD4+ T-cells and CD8+ T-
cells followed by the release of mediators like interferon gamma and interleukin2 (IL-
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2 and IFN) which in turn facilitates the binding of the CD4+ T-cells RCA receptor to 
the RCA present on the surface of CD8+ T-cells (Zhou et al., 2002; Sugerman et al., 
2002). 
3. Killing of basal keratinocytes - occurs by one of three mechanisms: 
 The activated CD8+ T-cell secrete Tumour Necrosis Factor alpha (TNF-α) 
which binds to the TNFR-1 on the surface of the basal keratinocytes thereby 
killing these cells. 
 FasL receptors located on the T-cells’ surface binds to Fas receptors on the 
cell membrane of the keratinocytes. 
 The secretion of granenzyme B via T-cells which enters the keratinocytes  
through membrane pores. 
All of these mechanisms subsequently activate the Caspase cascade, leading to 
apoptosis of keratinocytes (Sugerman et al., 2002; Ammar et al., 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Diagram showing the Hypothesis of pathogenesis of OLP (the antigen of lichen 
planus is expressed on the basal keratinocyte in association with MHC class I molecules on 
basal keratinocytes. Antigen-specific CD8+ T-cell after activation trigger apoptosis of 
keratinocyte via secreted TNF that bind to the receptor of TNF (TNF-R1) (Sugerman et al ., 
2002). 
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2.7.2  NON-SPECIFIC MECHANISMS 
 
Some of the T-cells’ lymphocytes infiltrated in OLP have been attracted to the 
superficial layer of lamina propria by numerous non-specific mechanisms. Sugerman et al. 
(2002) suggested that these mechanisms aim to destroy basal keratinocytes by migration of 
the lymphocytes to the epithelium and include the following: 
           2.7.2.1     EPITHELIAL BASEMENT MEMBRANE DESTRUCTION 
 
Basement membrane alteration like breaking, branching, duplication, or thickening is 
common in OLP disease (Jungell et al., 1988). Basal keratinocyte cells are essentially 
required for the maintenance of epithelial basement membrane structure integrity as it 
secretes Laminin V and Collagen IV (Marinkovich et al., 1993). However, due to the 
presence of apoptosis in keratinocytic cells these cells will no longer be able to perform this 
function resulting in the disruption of the basement membrane as is observed in OLP. 
Conversely, some evidence indicates that keratinocyte cells themselves require the basement 
membrane for maintenance and send the survival signal for termination of apoptosis (Pullan 
et al., 1996).  
Nevertheless, both apoptosis of keratinocytes as well as disruption of the epithelial 
basement membrane are implicated in the pathogenesis of OLP. The two mechanisms may 
indeed have occurred as a cyclic event where keratinocyte apoptosis might have been 
triggered by the disruption of the basement membrane, and apoptotic keratinocytes may not 
be capable of repairing the basement membrane disruption. Such cyclical events may be 
responsible for the chronicity of the lesion (Sugerman and Savage, 2002). 
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     2.7.2.2     MATRIX METALLOPROTEINASES 
 
Matrix MetalloProteinases (MMPs) belong to the zinc-containing endo-proteinases 
family. The main function of this enzyme is the proteolytic degradation of connective tissue 
matrix proteins. Activation of this enzyme leads to the disruption of the basement membrane 
through the release of the MMP’s activator from T-cells (Zhao et al., 2001; Sugerman and 
Savage, 2002).  
Keratinocyte survival signals cannot pass through the disrupted basement membrane 
thereby triggering the apoptosis of keratinocytes. Moreover, the passage of antigen-specific 
CD8+ T-cells into the OLP epithelium may facilitate the disruption of the basement 
membrane which can trigger more apoptosis of the keratinocytes (Moss et al., 1997; Itai et 
al., 2001). 
      2.7.2.3    MAST CELLS 
 
Mast cell density was reported to be increased in OLP (Zhao et al., 1997; Zhao et al., 
2001). Approximately 60% of such mast cells were degranulated in OLP, as compared with 
20% of degranulated mast cells found in the normal buccal mucosa (Zhao et al., 2001). These 
degranulated mast cells release a number of inflammatory mediators such as TNF-α, 
Chymase and Tryptase, which may up-regulate endothelial cell adhesion molecule 
expression. This in turn is required for lymphocyte adhesion to the luminal surface of blood 
vessels and subsequent extravasation (Klein et al., 1989; Zhao et al., 1997).  
In addition, clusters of mast cells and intra-epithelial CD8+ T-cells have been found 
at sites of basement membrane disruption in OLP (Zhao et al., 2002). Analysis of this data 
suggests that mast cells and CD8+ T-cell migration may play a role in epithelial basement 
membrane disruption in OLP.  
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     2.7.2.4    CHEMOKINES 
 
Chemokines are cytokines that are produced by virtually all somatic cells. RANTES 
(Regulated on Activation, Normal T-Cell Expressed and Secreted) is a member of the 
chemokines family which plays an important role in the recruitment of lymphocytes and mast 
cells in OLP.  
RANTES receptors like CCR1, CCR3, CCR4, CCR5, CCR9  have been identified in OLP 
(Zhao et al., 2001; Sugerman et al., 2002). The recruited mast cells undergo degranulation 
under the influence of RANTES, which releases Chymase and TNF-α, resulting in further up-
regulation of RANTES secretion by OLP lesion T-cells. This cyclical activity may underlie 
the chronicity of the lesion (Sugerman et al., 2002). 
     2.7.3    AUTOIMMUNITY  
 
It has been hypothesised that OLP disease is an autoimmune lesion.  This hypothesis is 
supported by numerous autoimmune features of oral lichen planus like adult onset, the 
chronicity of the disease, being more common in females, and its association with other 
autoimmune lesions (Sugerman et al., 2002). 
    2.7.4    HUMORAL IMMUNITY 
 
The presence of circulating antibodies including auto-antibodies reacting against 
Desmogleins 1 and 3 has been implicated in OLP patients. This finding suggests a role of 
humoral immunity in the pathogenesis of oral lichen planus (Lukač et al., 2006).  
2.8 DIAGNOSIS OF ORAL LICHEN PLANUS  
 
Due to the challenges in the correct diagnosis of OLP lesions, it is obligatory to 
include clinico-pathological correlation. In 1987, the WHO defined criteria for the diagnosis 
of OLP lesions which were modified in 2003 by Van der Meij and Van der Waal. According 
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to the clinical criteria, the lesion must be bilateral with the presence of interlacing white 
hyperkeratosis lines displaying a reticular pattern.  
             The other variants, which include erosive, plaque bullous and atrophic types, are 
accepted as subtypes in the presence of reticular lesions elsewhere in the mucosa of the oral 
cavity. The histopathological criteria involve the presence of the band of cellular infiltration 
composed mainly of lymphocytes in the superficial part of connective tissue, vacuolar or 
hydropic degeneration of the basal layer, and absence of epithelial dysplasia. They suggest 
the use of the term “histopathologically compatible” whenever the criteria are less obvious 
(Van der Meij and Van der Waal, 2003).  
2.8.1   DIRECT IMMUNOFLUORESCENCE 
 
  This is a useful technique to support the diagnosis. A characteristic of OLP lesions is 
the presence of a shaggy pattern of fibrinogen deposits along the basement membrane with 
absence of Complement and Immunoglobulin deposits (Crincoli et al., 2011). 
 
2.9  DIFFERENTIAL DIAGNOSIS OF ORAL LICHEN PLANUS  
 
These include Leukoplakia, cheek biting, Mucous membrane pemphigoid, lichenoid 
reactions, Candidiasis, Graft versus Host Disease (GVHD), frictional keratosis, Lupus 
erythematous, Pemphigus, Chronic ulcerative stomatitis and para-neoplastic Pemphigus 
(Lavanya et al., 2011). 
2.10  TREATMENT OF ORAL LICHEN PLANUS 
 
Due to the uncertainty of the pathogenesis of OLP many clinicians use immune-
suppressant corticosteroids as the first line of treatment for the disease (Scully et al., 2000; 
Lavanya et al., 2011). 
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OLP cases are occasionally resistant to corticosteroids due to genetic variability in 
lymphocyte sensitivity potential (Hearing et al., 1999; Creed et al., 2009; Nicolaides et al., 
2014). Such patients were administered with other options like calcineurin inhibitors which 
target T-cell activation and proliferation, or cytokine receptor inhibitors (Cheng et al., 2012; 
O’Neill and Scully, 2013). Furthermore, natural remedies such as green tea consumption 
have also been found to be useful in OLP treatment. Green tea is reported to prevent T-cells 
proliferation, antigen presentation, migration, activation and the apoptosis of keratinocytes 
(Zhang and Zhou, 2012).  
2.11  ORAL LICHENOID LESIONS (OLL) 
 
These lesions resemble OLP both histopathologically and clinically. While OLP does 
not have a specific aetiology, OLL’s have a defined or suspected cause in patients. Drugs are 
considered one of the major causes of lichenoid reactions in the oral mucosa and skin 
(McCartan and McCreary, 1997). Lichenoid lesions can also be caused by direct contact of 
the oral mucosa with dental restoration materials such as mercury, amalgam and resin 
materials (Östman et al., 1994; Blomgren et al., 1996). OLL could also be caused by 
flavouring agents in foods such as cinnamon. Some investigators described a focal type and 
diffuse type presentation of OLL on consumption of cinnamon-based candies and mouth 
rinses, respectively (Miller et al., 1992). 
One histopathological study aimed to differentiate OLP from OLL by correlating 
epithelium thickness and thickness of inflammatory infiltrate in other lesions. This study 
found that in lichenoid reactions, the relationship was positive between epithelial and 
inflammatory band thickness, whereas it was negatively correlated in cases of Lichen Planus 
(Usha et al., 2012). 
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2.12  APOPTOSIS 
 
  Apoptosis is a Greek word described by Kerr et al. which means falling as in the case 
of the falling of leaves from trees in autumn (Kerr et al., 1972). It is one of the mechanisms 
that maintain balance between dying cells and normal cells and is considered as programmed 
cell death (PCD) (Hanahan and Weinberg, 2011). While cell death involves several 
mechanisms like apoptosis, necrosis, autophagy, anoikis, necroptosis, entosis and 
cornification (Roychowdhury et al., 2013), the two main mechanisms are necrosis and 
apoptosis (Shuh et al., 2013).  
The microscopic alterations of apoptosis occur in two separate stages. The first stage 
comprises the nucleus and cytoplasm condensation and splitting of the cell into membranous 
fragments, whereas the second stage involves either shacking of the apoptotic body fragments 
from the cell’s surface or being phagocytosed by the phagocytic cells, which are subsequently 
degraded by a mixture of lysosome enzymes inside the phagosomes (Kerr et al., 1972).   
2.12.1   MECHANISMS OF APOPTOSIS 
 
Apoptosis usually occurs through two major pathways – the intrinsic (or 
mitochondrial) pathway and the extrinsic pathway (Fig 2.4). Another mechanism was also 
reported to initiate apoptosis which occurs by releasing perforin/granzyme from cytotoxic T- 
lymphocytes and NK cells (Martinvalet et al., 2005). 
2.12.1.1      INTRINSIC PATHWAY OF APOPTOSIS  
                  (MITOCHONDRIAL PATHWAY) 
 
  The mitochondrial pathway of apoptosis is mediated by pro-apoptotic members 
causing an increase in the permeability of the outer mitochondrial membrane which leads to 
Caspase activation (Green and Kroemer, 2004). Many initiators and stimuli such as; 
ultraviolet radiation, DNA damage, heat, the actions of tumour suppressor genes (i.e. p53), 
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viral virulence factors, chemotherapeutic agents and stress can initiate the intrinsic pathway 
of apoptosis (Kroemer, 2003). These cytotoxic stimuli trigger the permeability of the 
mitochondrial outer membrane and the mechanism is regulated by mitochondrial lipids and 
Bcl-2 family proteins (Decaudin et al., 1998; Green and Kroemer, 2004). This leads to the 
disruption of the outer mitochondrial membrane with consequent disintegration of numerous 
proteins located between the outer and inner mitochondrial membrane which is released into 
the cytosol where they trigger cell death by stimulating caspase-dependent and -independent 
pathways (Saelens et al., 2004). 
2.12.1.2        EXTRINSIC PATHWAY OF APOPTOSIS 
 
This is one of the major pathways and is also called receptor-mediated apoptosis. It is 
mediated through activation of the pro-apoptotic receptors located on the surface of cells. 
Some examples of these death receptors are the TNF-1 receptor (p55 or CD120a), Fas 
(CD95/APO-1), DR4 (TRAIL-R1) and DR5 (TRAIL-R2) which transmit apoptotic signals 
after their activation upon binding to molecules known as pro-apoptotic ligands (Elmore, 
2007; Henseleit et al., 1997). Activation of these receptors leads to the recruitment of adaptor 
proteins namely TNF receptor-associated protein with Death Domain (TRADD) and Fas-
associated protein with Death Domain (FADD) (Guicciardi and Gores, 2009). These adaptor 
proteins recruit and activate caspase 8 and caspase 10 (initiator caspases) through Death 
Effector Domains (DEDs) thereby leading to the formation of a complex known as the death-
inducing signalling complex (DISC) (Boatright and Salvesen, 2003; Guicciardi and Gores, 
2009).  The activation of these initiator caspases subsequently activates effector caspases 
causing degradation of cellular targets and apoptosis induction (Scaffidi et al., 1998). 
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Figure 4: Diagram showing the intrinsic and extrinsic apoptotic pathway (Anas and Roya,  
                 2008). 
 
 
2.12.2       SIGNIFICANCE OF APOPTOSIS IN BIOLOGICAL SYSTEMS 
 
 Apoptosis plays a key role during embryogenesis where it contributes in shaping 
tissues and organs in the body and maintaining normal homeostasis. During development, 
most cells are produced in excess and thereafter undergo apoptosis or PCD to develop in 
requisite form, as noticed in the development of the immune system, nervous system and 
reproductive organs (Meier et al., 2000). Apoptosis is also important in adult organism cells 
where it continues to maintain a balance between proliferation and cell death in order to 
maintain homeostasis of constant cell numbers (Rathmell and Thompson, 2002).    
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2.12.3     MALFUNCTIONING OF APOPTOSIS AND PATHOGENESIS 
 
Malfunctioning and dysregulation of apoptosis occurs either due to its down- or up-
regulation thereby causing many diseases in the body. Most prominent diseases like cancer, 
autoimmunity and other persistent infections largely occur due to insufficient apoptosis. 
Recently it was found that tumour formation occurs not only as a result of excessive 
proliferation of cells due to the activation of oncogenes, but also depends on the impairment 
of apoptosis checkpoints (Hanahan and Weinberg, 2000; Wang, 1998). On the contrary, 
diseases like neurodegenerative diseases (Parkinson’s disease, Alzheimer’s disease) and 
AIDS (caused by depletion of T -lymphocytes) largely occur due to excessive apoptosis 
(Reed, 2002). 
2.13  APOPTOSIS AND OLP 
 
Apoptosis in OLP has been hypothesised as one of the major underlying mechanisms 
involved in basal keratinocyte destruction (Lavanya et al., 2011). Occurrence of apoptosis in 
the keratinocytes of OLP lesions was first suggested by Hashimoto and it was assumed that 
the cytotoxic T-cells are involved in the apoptosis of basal keratinocytes (Hashimoto, 1976; 
Weedon, 1980; Roopashree, et al., 2010). Furthermore, it was reported that apoptosis 
increases significantly in OLP patients compared to the normal oral mucosa (Karatsaides, 
2003; Nelperg, 2007). Although apoptosis serves as an important histopathological feature of 
the OLP lesion (Burgdorf and Plewig, 2014), only a few studies are available to validate its 
relations with other histopathological features of OLP. It was suggested by Neppelberg et al., 
(2001) that increased apoptotic rates could be responsible for the decreased thickness of the 
oral epithelium. A couple of studies indicate that the increase in apoptotic rate is linked to an 
enhanced lymphocyte infiltration in OLP (Bloor et al., 1999; Doddawad, 2014). Other studies 
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revealed that the chronic inflammatory infiltrate is responsible for inhibition of the 
occurrence of apoptosis in the corresponding epithelium (O’Byrne and Dalgleish, 2001). 
 Results from studies conducted to determine the significance of apoptosis in the 
inflammatory infiltrate of OLP showed that the absence or low rate of apoptosis noticed in 
inflammatory cells in OLP seems to contribute to the persistence of the inflammatory 
infiltrate. This also heightens the influence of the onset of molecular disorders in epithelium 
and favour malignant transformation (Bascones et al., 2006).  
Further, the relationship between apoptosis and epithelial thickness was studied in the 
most common types of OLP i.e. the reticular and erosive forms by Brant et al. (2008). In 
apoptotic analysis performed through immunohistochemistry like TUNEL and M30 
CytoDEATH, apoptosis was found to be significantly increased in both reticular and erosive 
OLP cases in comparison to normal mucosa. However, the apoptotic intensity was much 
higher in cases of erosive OLP. Similar results were obtained regarding epithelial thickness 
where thickness was found to be greatest in normal mucosa followed by reticular and erosive 
OLP cases, respectively. Moreover, the study reported a significant negative correlation 
between the epithelial thickness and the apoptosis index (AI). Hence, the erosive OLP 
showed the thinnest epithelia and the highest AI (Brant et al., 2008). In an extended study, 
Brant et al. (2012) evaluated the role of apoptosis in reticular and erosive OLP, particularly in 
the epithelium and sub-epithelia inflammatory cell infiltrates. While the initial findings for an 
inverse correlation between the epithelium thickness and amount of apoptosis was reported 
similar to a previous study, different apoptotic levels were reported in the erosive and 
reticular forms of OLP, determining different clinical presentations. Regarding apoptotic 
activity in the inflammatory cell infiltrates, while the apoptosis index was found to be higher 
in reticular OLP in comparison to erosive OLP, the number of lymphocytes was less in 
reticular OLP, suggesting a negative correlation between apoptosis and lymphocytic content 
 
 
 
 
 21 
 
of infiltrates. Overall, that study concluded that a higher apoptosis index and a lower 
lymphocytic content in reticular OLP results in increased elimination of inflammatory cells, 
less inflammation, less aggression to epithelial cells, and reduced epithelial apoptosis. On the 
contrary, in case of erosive OLP, less apoptosis and high lymphocytic content in the 
inflammatory infiltrate cause persistent lymphocyte recruitment with continuous 
inflammation and aggression towards epithelium (Brant et al., 2012). 
Although involvement of apoptosis in basal cell degeneration in OLP has been 
reported, research findings regarding the correlation between apoptosis and histopathological 
characteristics of OLP are highly sparse. Hence, the present study aims to investigate the 
association of apoptosis with epithelial thickness and the inflammatory infiltrate in OLP. It is 
expected that findings from this study will aid in enhancing the in-depth understanding of the 
role of apoptosis in OLP, as well as its association with other histopathological features.  
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CHAPTER 3 
 
 RESEARCH METHODOLOGY 
3.1  AIM 
 To determine and correlate the apoptotic rate with the epithelial thickness and band-
like lymphocytic infiltration in H & E sections of OLP samples diagnosed at 
Tygerberg hospital from 2006 – 2015. 
 To gauge the possible association of the sub-epithelial chronic inflammatory infiltrate 
with the thickness of the overlying epithelium.  
3.2   OBJECTIVES 
A)    To determine the apoptotic rate of histologically diagnosed cases of OLP.  
B)    To evaluate the thickness of the epithelium and band-like lymphocytic infiltrate in 
OLP. 
C)    To correlate the findings in “A” and “B.” 
D)  To determine the correlation between the thickness of epithelium and band-like 
lymphocytic infiltrate. 
3.3  MATERIALS AND METHODS 
 
3.3.1 STUDY DESIGN 
 
The study was performed as a retrospective study where the data for the patients diagnosed 
clinically as well as histologically with OLP were retrieved from the Department of Oral 
Medicine & Periodontics at Tygerberg Oral Health Centre, Cape Town, South Africa during 
the period between 2006 and 2015. Prior to the study, ethical approval was acquired from the 
Human Health Research Ethics Committee of UWC and in lieu of research ethics, the 
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patient’s data was displayed as a registration code number rather than by their name, for 
identification purposes. All archived files of patients with OLP diagnosed in the period 
between 2006 and 2015 were retrospectively reviewed, and a total of 29 cases diagnosed as 
OLP were selected from the aforementioned period.  The corresponding histopathology slides 
were accessioned from the Anatomical Pathology archives of the National Health Laboratory 
Service at Tygerberg hospital.  The clinical files and histological material were further 
screened based on the following inclusion and exclusion criteria based on the modified WHO 
clinical and histopathological diagnostic criteria, proposed by Van der Meij and Van der 
Waal (2003).   
3.3.1.1     CLINICAL CRITERIA 
 
The clinical criteria stipulate that the lesions must be bilateral with the presence of 
interlacing white hyperkeratosis lines (reticular pattern). The other variants include erosive, 
plaque, bullous and atrophic types which are accepted subtypes in the presence of reticular 
lesions elsewhere in the mucosa of the oral cavity. Patients receiving drug treatment or with 
non-symmetrical or unilateral lesions were excluded in order to avoid possible diagnostic 
confusion with lichenoid reactions. 
3.3.1.2     HISTOPATHOLOGICAL CRITERIA 
 
  Only specimens obtained from the buccal mucosa were used for morphometric 
analysis in order to avoid histological differences due to the differing anatomical origins of 
the samples. The inclusion criteria comprised the presence of sufficient epithelium and a 
band-like inflammatory infiltration in the submucosa with deeper connective tissue. The 
presence of the band of cellular infiltration had to be composed mainly of lymphocytes in the 
superficial part of connective tissue intermingling with the epithelial basal layer (interface 
mucositis) resulting in vacuolar or hydropic degeneration of the basal layer. There had to be 
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an absence of fungal infection or epithelial atypia in order to avoid possible or other 
processes that can develop immune reactions in the corium.  Cases with any tissue artefact or 
lack of inflammation were also not considered for inclusion in the study. 
 
 
3.3.2      HISTOPATHOLOGY ANALYSIS  
 
Based on the above stringent screening measures, 17 paraffin block samples were 
selected out of these 29 cases and were recut for histopathological analysis as mentioned 
below: Paraffin blocks, containing fixed OLP tissues in 10% buffered neutral formalin 
solution, of each of these 17 samples were sectioned. The 4 μm sections of each sample were 
stained with H & E staining using an automated stainer. All slides were further examined for 
determination of apoptotic cells as well as sub-epithelial and epithelial band thickness as 
described below. 
 
                                 
 
Figure 5: Diagram showing wax block of OLP specimen. 
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Figure 6: Photograph showing a rotary microtome and a water bath. 
 
 
 
 
 
 
 
 
 
 
Figure 7: Photograph showing an automated H&E stainer (LEICA). 
 
 
 
 
 
 
 
 
 26 
 
 
3.3.2.1      DETECTION OF APOPTOTIC CELLS 
 
Using a camera attached to a digital imaging microscope, representative images of H 
& E sections of OLP cases were taken. Apoptotic cells were identified in the basal and 
intermediate layers based on the following criteria put forward by Bloor et al., (1999): 
•    Cell shrinkage. 
•    Chromatin condensation at the periphery of the nucleus. 
•    Uniform eosinophilic cytoplasm. 
•    Nuclear and/or cytoplasmic fragmentation. 
•    Nuclear pyknosis. 
•    Nucleolar disintegration. 
The total number of apoptotic cells were counted and recorded in 131 adjacent 250 
μm wide fields of the section; the same areas were used for measuring the other 
histopathological parameters (thickness of the epithelium and corresponding inflammatory 
infiltrate). 
 
 
 
  
 
 
 
 
Figure 8: Photograph showing a digital imaging microscope. 
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3.3.2.2  MEASUREMENT OF EPITHELIAL AND SUB-EPITHELIAL 
INFLAMMATORY BAND THICKNESS 
 
The epithelial thickness and the thickness of the sub-epithelial band of inflammatory 
infiltrate was measured in 131 adjacent 250 μm wide fields of the sections in the same areas 
where the apoptotic bodies were counted. The epithelium was measured from the superficial 
keratotic area to the basal layer of the epithelium. The band of inflammatory infiltrate was 
measured in sub-epithelial connective tissue. Five measurements of the inflammatory 
infiltrate thickness were taken from each region (each 250 μm wide) at 12 x magnification 
with a 20 x plane achromatic objective. The average of five measurements of epithelium and 
inflammatory infiltrate was calculated and correlated with the number of apoptotic bodies. 
All measurements were made by using a free modular image-processing and analysis 
software for digital microscopy (ZEN Blue Lite, 2012). The results were entered into an 
Excel
®
 spreadsheet (Microsoft 2010, USA) for statistical analysis. The data was analysed 
statistically by using R statistical software program (R Core Team
®
, 2013). 
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CHAPTER 4 
 
 RESULTS 
 
4.1  SOCIODEMOGRAPHIC FEATURES OF THE SAMPLE 
 
The selected patients’ gender and age of onset of OLP was recorded. An almost 
equivalent gender ratio was observed in OLP patients, with 52.94% females and 47.05% 
males (9 females and 8 males), as illustrated in figure 9. Furthermore, the average age of 
patients with OLP was 52 years with an overall age range of 29 to 69 years. 
 
 
 
 
 
 
 
Figure 9: Gender ratio among OLP patients. 
4.2  HISTOPATHOLOGICAL FEATURES 
 
The histopathological features comprised interface mucositis with vacuolar 
degeneration of the basal epithelial layer and a sub-epithelial band of lymphocytic 
inflammatory infiltrate with absence of epithelial dysplasia in all the included cases. 
Furthermore, epithelial hyperkeratosis with spherical eosinophilic hyaline bodies (apoptotic 
bodies) was also noticed in the study samples. 
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4.3  RELATIONSHIP BETWEEN EPITHELIUM THICKNESS OR 
INFLAMMATORY INFILTRATE AND NUMBER OF APOPTOSIS  
 
Correlation between epithelium thickness and number of apoptosis can be interpreted as 
a tendency for epithelium thickness to increase or decrease systematically with apoptosis and 
vice versa. There are several regions for every case which makes it possible to examine the 
relation between the two variables in two ways: viz. by examining the correlation between 
the two variables within cases and between cases. The statements above also apply to the 
thickness of inflammatory infiltrate.  
4.3.1  RELATIONSHIP BETWEEN EPITHELIUM THICKNESS AND NUMBER OF 
APOPTOSIS (WITHIN CASE ASSOCIATION) 
 
  The association between epithelium thickness and number of apoptosis within cases 
was assessed separately for each case using the Poisson regression analysis method with the 
intercept equal to zero. The dependent variable was number of apoptosis and the independent 
variable was epithelium thickness. The results of the Poisson regression equation for the 17 
cases are given in Table 1. The findings indicate that there are no significant differences 
between the thickness of epithelium and number of apoptosis within the 17 cases.   
Figure 10 demonstrates a plot of number of apoptosis versus epithelium thickness for all 
cases, each case represented by a different symbol. The results expressed in this figure are in 
agreement with the results of the regression analyses, as no upward or downward trend in 
epithelium thickness was found with the number of apoptotic bodies. 
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Case Epithelial slopes p-values Significance   
1 0.004 0.291 No 
2 -0.005 0.148 No 
3 -0.01 0.319 No 
4 0.015 0.091 No 
5 0.005 0.337 No 
6 -0.004 0.559 No 
7 -0.003 0.614 No 
8 -0.001 0.864 No 
9 0.042 0.026 No 
10 -0.033 0.368 No 
11 -0.005 0.499 No 
12 0 1 No 
13 -0.008 0.399 No 
14 0.001 0.746 No 
15 -0.005 0.586 No 
16 -0.002 0.231 No 
17 0.003 0.352 No 
 
Table 1: Showing the epithelial slopes and the epithelial p-values. 
 
 
 
 
Figure 10: Diagram showing the relationship between epithelium thickness (m. Epithel) and 
number of apoptosis (m. apop) (The different symbols represent different cases). 
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4.3.2      RELATIONSHIP BETWEEN INFLAMMATORY INFILTRATE AND   
NUMBER OF APOPTOTIC BODIES (WITHIN CASE ASSOCIATION) 
 
The correlation between the inflammatory infiltrate thickness and rate of apoptosis for 
each case was calculated as in section 4.3.1. The columns named inﬂammatory slopes and 
inﬂammatory p-values in Table 2 show results similar to epithelium thickness results for the 
variable inflammatory infiltrate. No statistically significant results were shown in the 17 
cases, none of the p-values were less than 0.05 and the slopes of 10 cases were positive. The 
conclusion is as for epithelium thickness, namely that there is no within case correlation 
between the thickness of inflammatory infiltrate and the number of apoptotic bodies (Figure 
11). 
 
 
 
Figure 11: Diagram showing the relationship between thickness of inflammatory  
                   infiltrate (m.infl )and number of apoptosis (m. apop). 
             (The different symbols represent different cases) 
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Case Inflammatory infiltrate slopes Inflammatory infiltrate p-values 
1 0.007 0.291 
2 0.004 0.211 
3 0.012 0.776 
4 -0.006 0.091 
5 -0.004 0.194 
6 -0.009 0.34 
7 0.001 0.876 
8 -0.001 0.721 
9 0.011 0.192 
10 0.017 0.742 
11 -0.005 0.187 
12 0 1 
13 -0.011 0.211 
14 0.002 0.707 
15 0.008 0.392 
16 -0.003 0.083 
17 0.01 0.022 
 
 Table 2: Showing the inﬂammatory slopes and the inﬂammatory p-values 
 
 
4.4  RELATIONSHIP BETWEEN EPITHELIUM THICKNESS AND NUMBER OF  
            APOPTOSIS (BETWEEN CASE ASSOCIATION) 
 
In this study, the mean values of the three variables: epithelial thickness, 
inflammatory infiltrate and rate of apoptosis calculated for each case are represented in Table 
3 (see below). 
Figure 12 demonstrates a plot of the mean number of apoptotic counts versus the 
mean epithelial thickness values. It indicates no significant correlation between the two 
variables. The correlation coeﬃcient (Pearson) is 0.136, non-signiﬁcant p-value = 0.602. 
Similarly, Figure 13 represents a plot of the values for the mean number of apoptosis vs the 
values for the mean inflammatory infiltrate. No correlation was found between the two 
variables; the Pearson correlation coeﬃcient is 0.000; non-signiﬁcant p-value >0.999. 
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When the between case correlation coefficients (Pearson coefficient) were calculated 
for mean epithelial thickness and inflammatory infiltrate, no statistically significant results 
were obtained, the mean Pearson correlation coeﬃcient was 0.011, p-value= 0.968, not 
signiﬁcant. (r = 0.011, p = 0.968) (Figure 14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Plot Diagram showing the lack of relationship between the mean epithelium 
thickness values (mm.Epithel) and the mean apoptotic counts (mm.apop ). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Plot Diagram showing the lack of relationship between the mean of the 
inflammatory infiltrate values (mm. infl) and the mean number of apoptosis values 
(mm. apop). 
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Figure 14: Plot Diagram showing the lack of relationship between the mean  epithelium 
thickness values (mm. Epithel) and the mean of the inflammatory infiltrate values (mm. infl).  
 
 
          
 
 
 
 
 
 
 
 
 
                  Table 3:  Represents the mean values of the three variables. 
Case  mm. Epithelial 
thickness 
mm. inflammatory 
infiltrate 
mm. 
apoptosis   
1 155.32   μm 272.36   μm 2.2    
2 309.096 μm   126.679 μm 1 
3 205.9     μm 54.667   μm     0.833 
4 201.05   μm 453.275 μm 0.625 
5 288.707 μm 236.053 μm 1.4 
6 261.85   μm 261.675 μm 0.625 
7 354        μm 128.6     μm 1.625 
8 322.644 μm 398.667 μm 1.444 
9 121.15 μm 445.872 μm 0.667 
10 131.44 μm 272.72   μm 0.2 
11 298.96 μm 383.08   μm 2 
12 279.8    μm 273.25   μm 0 
13 153      μm 243.6     μm 1.5 
14 322.6   μm 99.688   μm 2 
15 335.56 μm 791.44   μm 0.6 
16 240.575μm 696.463 μm 2.75 
17 226.2   μm 174.133 μm 2.333 
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CHAPTER 5 
 
      
5.1     DISCUSSION  
 
OLP is a chronic inflammatory disease mainly affecting the mucosal membranes of the 
oral cavity and the skin. It may also affect skin appendages (for example, nails) and other 
mucosal membranes (for example, the genitalia and oesophagus) (Le Cleach and Chosidow, 
2012). Since the pathogenesis of OLP has been poorly understood and it is unclear exactly 
which molecular mechanisms play key roles in the underlying clinical manifestations and 
presentations, the present study aimed to investigated the possible role of apoptosis in OLP.  
In the current study, an immense effort was invested in the selection of suitable cases. 
The majority of the cases registered in the department of Oral Medicine and Periodontics 
were lichenoid type reactions, rather than OLP and were therefore excluded from the study. 
For the diagnosis of OLP cases, clinico-pathological correlation was performed using the 
modified WHO criteria (Van der Meij and Van der Waal, 2003). Furthermore, stringent 
selection criteria were applied to ensure that patients included in the study did not suffer from 
any other diseases or used medications, or their lesions had non-typical histopathological 
features.  This exercise resulted in relatively small study sample (17 cases), however this was 
compensated by histologically measuring numerous small adjacent fields of 250 μm wide. 
In the present study, the incidence of OLP was found at the mean age of 52 years. 
Additionally, the prevalence of OLP was observed to be slightly higher in females when 
compared to males. These observations are in agreement with previous published reports 
which revealed that OLP is more frequent in females than in males with a higher incidence in 
older patients (Ingafou et al., 2006; Pakfetrat et al., 2009). 
Microscopically, the study observed three histopathological criteria of OLP in all the 
study samples, namely: vacuolar degeneration of the basal epithelial layer; a sub-epithelial 
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band of lymphocytic inflammatory infiltrate consisting mainly of T-lymphocytes with 
absence of epithelial dysplasia; and epithelial hyperkeratosis. These findings are also in 
accordance with other studies (Van der Meij and Van der Waal, 2003; Batra et al., 2008; Hall 
et al., 2008). In a study conducted by Juliana et al (2008), the presence of spherical 
eosinophilic hyaline bodies (apoptotic bodies) was reported in the basal and parabasal 
epithelial layers. It has been reported that such structures occur due to the programmed 
destruction of basal keratinocytes by apoptosis. The present study expressed similar findings 
thereby providing further evidence for the apoptosis-mediated basal keratinocytes cell death.  
In the present study, considerable amounts of apoptotic cells were noticed in the basal 
and intermediate layers despite the fact that the identification and counting of apoptotic cells 
was a difficult and tedious task, often due to the presence of the highly intense interface 
mucositis. Furthermore, measuring the thickness of the epithelium proved difficult due to the 
degeneration of cells and variable density of lymphocytes in side-to-side assessment of 
lymphocyte infiltration. Further, the restricted occurrence of apoptosis in the basal / parabasal 
layers was only explained by the fact that these layers are the most prone to damage by the 
associated sub-epithelial lymphocytic infiltrate. Results regarding the presence and role of 
apoptosis in OLP cases are highly debatable. Several studies including our study supported 
the impact of apoptosis in oral lichen planus progression (Brant et al., 2008 & 2012; 
Doddawad, 2014). Studies conducted by Brant et al., had detected apoptotic cells using 
sensitive immunohistochemistry assays like TUNEL and M30 CytoDeath. Further, the 
authors reported an overall increase in apoptosis in both erosive and reticular subtypes as well 
as in both epithelia and inflammatory infiltrate in comparison to normal mucosa, although the 
intensity was higher in epithelia (Brant et. al., 2008 & 2012). Similar results were revealed in 
another study where apoptosis within the epithelium was significantly increased in OLP, 
compared to normal oral mucosa, and seems to be related to the decreased thickness of the 
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oral epithelium (Neppelberg et al., 2001). Although the present study was not able to conduct 
the immunohistochemical analysis for the apoptotic index due to facility and antibody-related 
constraints, the study by Neppelberg et al (2001) strongly supports the findings of the present 
study. In addition, similar results were also reported in another recent study where an 
increased apoptotic count was reported in 40 OLP sections stained through H & E staining 
(Doddawad, 2014). Moreover, the current research findings regarding the presence of high 
numbers of apoptotic bodies in the epithelium was in corroboration with another study where 
higher numbers of apoptotic cells were reported in hematoxylin and eosin stained sections 
than in situ end labelling (ISEL), in OLP and normal buccal epithelium (Bloor et. al., 1999). 
On the contrary, a few authors observed no significant impact of apoptosis in the 
pathogenesis of OLP (Karatsaides et al., 2003; Bascones et al., 2007). They believe that the 
cells which are seen as shrunken and condensed cells in the epithelium are intra-epithelial 
lymphocytes but not apoptotic bodies. In addition, the deviations may also be attributed to the 
use of samples at different disease stages as the presence of intense and ulcerated lesions 
during the advanced disease stages may not be ideal to accurately identify and quantify 
programmed cell death. 
Although apoptosis has been implicated in OLP pathogenesis, its association with 
other clinical and pathological features has not been extensively explored. The present study 
aimed to determine the existence of any correlation between the apoptotic index and 
epithelial or inflammatory infiltrate thickness but found no significant association. These 
outcomes are not in corroboration with the majority of the studies which reported a negative 
correlation between increased apoptotic rates and decreased thickness of the oral epithelium 
in OLP (Neppelberg et al., 2001; Brant et al., 2012; Doddawad, 2014). However, a study 
conducted by Karatsaides and his co-workers is consistent with our study, as they were not 
able to observe any reduction in epithelial thickness with increased apoptosis using the 
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TUNEL marker. Their study proposed that the decrease in the oral epithelial thickness could 
be due to abnormal or premature terminal differentiation of the keratinocytes (Karatsaides et. 
al., 2003). 
Similarly, no correlation was observed between the apoptotic index and the thickness 
of the subepithelial inflammatory infiltrate, although a trend for a positive correlation was 
noticed (the apoptotic rate increased with increased thickness of the inflammatory infiltrate). 
Multiple studies revealed a positive correlation between the number of apoptotic bodies and 
the thickness of the inflammatory infiltrate (Bloor et al., 1999; Doddawad, 2014). The 
presence of the band-like lymphocyte infiltrate in the superficial part of the lamina propria 
has long been implicated as one of the main histopathological features of OLP.  
The present study also assessed the association between the thickness of the sub-
epithelial chronic inflammatory infiltrate and the squamous epithelial thickness. The evidence 
regarding the relationship between the two variables is highly sparse. One of the studies 
undertaken by Usha and co-workers (2012) determined the histopathological differentiation 
between OLP and lichenoid type reaction by using micrometry to gauge if the sub-epithelial 
chronic inflammatory infiltrate had any impact on the thickness of overlying epithelium. 
Their study included 30 cases of OLP and 10 cases of lichenoid reactions, studied by using an 
eye-piece graticule. The measurements of epithelial thickness and sub-epithelial 
inflammatory band thickness were taken in these lesions. Their results showed a negative 
correlation between epithelial thickness and band of inflammatory infiltrate in lichen planus 
cases; and a positive relationship in lichenoid lesions (Usha et al., 2012). However, the 
results of a recent study conducted by Ramya et al., (2014) were in disagreement with the 
former study. While evaluating the correlation between epithelium and inflammatory cell 
infiltrate thickness measured by using image analysis, the authors reported a direct influence 
of inflammatory cell infiltrate and epithelium thickness. They stated that the thickness of the 
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overlying epithelium decreases as the thickness of inflammatory infiltrate increases (Ramya 
et al., 2014). However, these study outcomes were not reproduced in the present study as no 
significant correlation was found between the two variables (Usha et al., 2012; Ramya et al., 
2014). This may possibly be due to the differences in the methodological approach. While the 
previous reports used highly sensitive immunohistochemical apoptotic markers like TUNEL, 
CASPASE 3, M30 CYTODEATH where it is easy to detect more apoptotic bodies, the 
present study detected the same using H&E staining. Other possible reasons for the non-
accordance of the present study outcomes with previous reports were the study in a different 
population group (Western Cape, South Africa) and the small sample size meeting the 
stringent diagnostic criteria for true OLP. 
5.2  LIMITATIONS  
 
 Very few studies have been conducted on the relationship between apoptosis, 
epithelial thickness and corresponding inflammatory infiltrate in OLP. This limits the 
scope for comparison of our research findings with published results and therefore no 
firm conclusions can be derived from this study. 
 The storage conditions of the wax blocks might have affected the identification and 
detection rate of apoptotic bodies.  
 Detection of the apoptotic bodies was performed by using H&E staining instead of 
using immunohistochemical markers; hence limiting the ability to identify and count 
apoptotic bodies. 
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5.3  CONCLUSION 
 
Based on the present study outcomes, it is suggested that the apoptotic rate might not 
have a significant influence on the thickness of overlying epithelium and does not correlate 
with the thickness of the corresponding inflammatory infiltrate in OLP.  Also, the 
inflammatory infiltrate thickness does not impact on the thickness of the overlying epithelium 
and further immunological and molecular studies are required for stronger evidence of non- 
correlation of apoptotic activity with the key histological parameters of OLP. 
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APPENDIX – Table showing raw data  
REGIONS CASE M.EITHE1 (μm) M.INFL(μm) M.APOP 
1 1 108     240.8 2 
2 1 96 233.6 3 
3 1 85.8 226.2 0 
4 1 245.8 337 3 
5 1 241 324.2 3 
1 2 330.6 83.8 0 
2 2 211.2 107 0 
3 2 381.4 67.4 2 
4 2 411.33 132.6667 0 
5 2 313.6 99.4 0 
6 2 242.6 144 3 
7 2 357.8 108.8 0 
8 2 300.2 331.6 2 
9 2 278.6 137.6 2 
10 2 360.6 155.2 1 
11 2 211.4 121.4 1 
12 2 185.4 97 2 
13 2 329 104.4 0 
14 2 372.6 107.4 1 
15 2 361.2 94.6 0 
16 2 298 134.6 2 
1 3 168 72.4 1 
2 3 231.6 50.6 0 
3 3 159 63.2 2 
4 3 159.8 48 0 
5 3 219.8 40.6 2 
6 3 297.2 53.2 0 
1 4 260.6 350.8 1 
2 4 279.2 227.2 1 
3 4 256 411.6 1 
4 4 136.8 461 0 
5 4 153.4 493 0 
6 4 171 713.2 0 
7 4 146.6 578.6 0 
8 4 204.8 390.8 2 
1 5 290.6 197 4 
2 5 247.4 134 3 
3 5 258 128.4 0 
4 5 271.2 182.6 2 
5 5 346.4 177.6 3 
REGIONS CASE M.EITHE1(μm) M.INFL(μm) M.APOP 
6 5 363.2 234.8 1 
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7 5 316.2 159.4 2 
8 5 286.4 200.4 0 
9 5 287 304.8 1 
10 5 283.4 221.4 1 
11 5 217.4 344.8 1 
12 5 224.4 368 0 
13 5 321.2 332.6 2 
14 5 328.2 330 1 
15 5 289.6 225 0 
1 6 348.8 262.4 0 
2 6 305.2 278.6 0 
3 6 240.6 232.2 1 
4 6 246.4 216 1 
5 6 297.2 263.6 0 
6 6 129.4 274 0 
7 6 205.6 188.6 2 
8 6 321.6 378 1 
1 7 388.6 49 0 
2 7 336.8 67.8 2 
3 7 371.6 106.4 5 
4 7 408.2 120.4 0 
5 7 268.4 205.6 3 
6 7 284 199.6 0 
7 7 374.6 143.2 1 
8 7 399.8 136.8 2 
1 8 308 441.2 2 
2 8 325 300.6 0 
3 8 302.4 331.2 2 
4 8 336 367.6 1 
5 8 332.8 455.8 0 
6 8 395.2 515 1 
7 8 292.4 541 3 
8 8 247.8 457.8 1 
9 8 364.2 177.8 3 
1 9 83.75 492.25 0 
2 9 117.2 462.8 1 
3 9 156.6 452.8 1 
4 9 137 451.2 1 
5 9 112.8 400.4 0 
6 9 110.2 444.6 0 
7 9 77.4 384.4 0 
REGIONS CASE M.EPITHE1(μm) M.INFL(μm) M.APOP 
8 9 156.6 531.8 2 
9 9 138.8 392.6 1 
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1 10 158.2 304.2 0 
2 10 158.8 262.6 0 
3 10 147 269.8 0 
4 10 105 279 1 
5 10 88.2 248 0 
1 11 257 497.2 1 
2 11 384.2 479 1 
3 11 280.8 253.6 3 
4 11 306.2 341.8 2 
5 11 266.6 343.8 3 
1 12 319.8 299.2 0 
2 12 325.6 322.2 0 
3 12 160.2 279.6 0 
4 12 313.6 192 0 
1 13 194.6 225 0 
2 13 158.4 298 0 
3 13 142.2 287 2 
4 13 169.2 212.8 2 
5 13 161.4 269.6 1 
6 13 98.6 241 2 
7 13 127.2 223.8 2 
8 13 172.4 191.6 3 
1 14 326.4 107.2 4 
2 14 451.6 47.2 2 
3 14 264 135 1 
4 14 328.4 38.5 0 
5 14 347.8 64 3 
6 14 345.6 104.2 2 
7 14 271.6 126 2 
8 14 245.4 175.4 2 
1 15 349.4 828.6 1 
2 15 285 889.8 1 
3 15 309.4 746.4 1 
4 15 267.8 740.6 0 
5 15 466.2 751.8 0 
1 16 124.6 648.8 1 
2 16 159.4 456.2 4 
3 16 190.4 691.4 5 
4 16 133.4 751 4 
5 16 160.8 851.4 1 
6 16 263.4 568.5 5 
7 16 452 718.8 1 
8 16 440.6 885.6 1 
1 17 66.4 84 0 
REGIONS CASE M.EPITHE1(μm) M.INFL (μm) M.APOP 
2 17 386.2 143.4 2 
3 17 226 295 5 
 
 
 
 
 
